The Perceptions, Barriers, and Opportunities for Anti-Obesity Medications in Obesity Care

3 days ago 3

The OBSERVE study identified important differences in the perceptions of obesity and anti-obesity medications between healthcare providers and people living with obesity and overweight. While healthcare providers viewed obesity as a disease requiring treatment, people with obesity viewed obesity as a self-modifiable condition. ¹

Join Dr. Lee Kaplan, Director of Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, to learn more about the OBSERVE study.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

This program has received financial support from Eli Lilly and Company (Lilly).

This disease-state program is intended solely for educational purposes.

All materials or information provided by Lilly for this learning program and all editorial control comply with applicable regulatory, legal, and medication compliance standards.

Presentation content is not approved for continuing education credit.

Developed under the direction and sponsorship of Lilly Medical Affairs and is intended for US healthcare professionals only.

Cite this: The Perceptions, Barriers, and Opportunities for Anti-Obesity Medications in Obesity Care: A Survey of Patients, Providers, and Employers - Medscape - Jun 27, 2024.

Read Entire Article